Pulmonary delivery systems for polyphenols

References

• World Health Organization. Chronic respiratory diseases. Available at: http://www.who.int; 2009.
   Google Scholar
• Silberberg M, Morand C, Mathevon T, et al. The bioavailability of polyphenols is highly governed by the capacity of the intestine and of the liver to secrete conjugated metabolites. Eur J Nutr 2006;45:88–96.
   PubMed Web of Science ®Google Scholar
• Bravo L. Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance. Nutr Rev 1998;56:317–33.
   PubMed Web of Science ®Google Scholar
• Tsao R. Chemistry and biochemistry of dietary polyphenols. Nutrients 2010;2:1231–46.
   PubMed Web of Science ®Google Scholar
• Heim KE, Tagliaferro AR, Bobilya DJ. Flavonoid antioxidants: chemistry, metabolism and structure-activity relationships. J Nutr Biochem 2002;13:572–84.
   PubMed Web of Science ®Google Scholar
• Gülçin I. Antioxidant activity of food constituents: an overview. Arch Toxicol 2012;86:345–91.
   PubMed Web of Science ®Google Scholar
• Quiñones M, Miguel M, Aleixandre A. Beneficial effects of polyphenols on cardiovascular disease. Pharmacol Res 2013;68:125–31.
   PubMed Web of Science ®Google Scholar
• Halliwell B. Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs Aging 2001;18:685–716.
   PubMed Web of Science ®Google Scholar
• Scalbert A, Manach C, Morand C, et al. Dietary polyphenols and the prevention of diseases. Crit Rev Food Sci Nutr 2005;45:287–306.
   PubMed Web of Science ®Google Scholar
• Sharma S, Rana S, Patial V, et al. Antioxidant and hepatoprotective effect of polyphenols from apple pomace extract via apoptosis inhibition and Nrf2 activation in mice. Hum Exp Toxicol 2016;35:1264–75.
   PubMed Web of Science ®Google Scholar
• Catel-Ferreira M, Tnani H, Hellio C, et al. Antiviral effects of polyphenols: development of bio-based cleaning wipes and filters. J Virol Methods 2015;212:1–7.
   PubMed Web of Science ®Google Scholar
• Yang X, Jiang X. Antifungal activity and mechanism of tea polyphenols against Rhizopus stolonifer. Biotechnol Lett 2015;37:1463–72.
   PubMed Web of Science ®Google Scholar
• Daglia M. Polyphenols as antimicrobial agents. Curr Opin Biotechnol 2012;23:174–81.
   PubMed Web of Science ®Google Scholar
• Karunaweera N, Raju R, Gyengesi E, et al. Plant polyphenols as inhibitors of NF-κB induced cytokine production—a potential anti-inflammatory treatment for Alzheimer’s disease? Front Mol Neurosci 2015;8:24
   PubMed Web of Science ®Google Scholar
• Zhang Y-J, Gan R-Y, Li S, et al. Antioxidant phytochemicals for the prevention and treatment of chronic diseases. Molecules 2015;20:21138–56.
   PubMed Web of Science ®Google Scholar
• Zhang H, Tsao R. Dietary polyphenols, oxidative stress and antioxidant and anti-inflammatory effects. Curr Opin Food Sci 2016;8:33–42.
   Web of Science ®Google Scholar
• Yordi EG, Pérez EM, Matos MJ, et al. Antioxidant and pro-oxidant effects of polyphenolic compounds and structure?activity relationship evidence. In: Bouayed J, Bohn T, eds. Nutrition, well-being and health. Rijeka, Croatia: InTech; 2012:23–48.
   Google Scholar
• Tsao R, Li H. Antioxidant properties in vitro and in vivo: realistic assessments of efficacy of plant extracts. In: Hemming D, ed. Plant sciences reviews. Wallingford, UK: CABI; 2012:11–17.
   Google Scholar
• Perron NR, Brumaghim JL. A review of the antioxidant mechanisms of polyphenol compounds related to iron binding. Cell Biochem Biophys 2009;53:75–100.
   PubMed Web of Science ®Google Scholar
• Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420:860–7.
   PubMed Web of Science ®Google Scholar
• Akula US, Odhav B. In vitro 5-lipoxygenase inhibition of polyphenolic antioxidants from undomesticated plants of South Africa. J Med Plants Res 2013;2:207–12.
   Google Scholar
• Bellik Y, Boukraâ L, Alzahrani HA, et al. Molecular mechanism underlying anti-inflammatory and anti-allergic activities of phytochemicals: an update. Molecules 2012;18:322–53.
   PubMed Web of Science ®Google Scholar
• MacNee W. Oxidative stress and lung inflammation in airways disease. Eur J Pharmacol 2001;429:195–207.
   PubMed Web of Science ®Google Scholar
• D’Acquisto F, May MJ, Ghosh S. Inhibition of nuclear factor kappa B (NF-κB). Mol Interv 2002;2:22.
   PubMedGoogle Scholar
• Granado-Serrano AB, Martín MA, Bravo L, et al. Quercetin modulates NF-kappa B and AP-1/JNK pathways to induce cell death in human hepatoma cells. Nutr Cancer 2010;62:390–401.
   PubMed Web of Science ®Google Scholar
• Kirkham P, Rahman I. Oxidative stress in asthma and COPD: antioxidants as a therapeutic strategy. Pharmacol Ther 2006;111:476–94.
   PubMed Web of Science ®Google Scholar
• Corrigan C, Kay A. The roles of inflammatory cells in the pathogenesis of asthma and of chronic obstructive pulmonary disease. Am Rev Respir Dis 1991;143:1165–8.
   PubMed Web of Science ®Google Scholar
• Moldoveanu B, Otmishi P, Jani P, et al. Inflammatory mechanisms in the lung. J Inflamm Res 2009;2:1–11.
   PubMedGoogle Scholar
• Oudijk ED, Lammers JJ, Koenderman L. Systemic inflammation in chronic obstructive pulmonary disease. Eur Respir J 2003;22:5s–13s.
   Web of Science ®Google Scholar
• Wouters EF, Groenewegen KH, Dentener MA, et al. Systemic inflammation in chronic obstructive pulmonary disease: the role of exacerbations. Proc Am Thorac Soc 2007;4:626–34.
   PubMedGoogle Scholar
• Reuter S, Gupta SC, Chaturvedi MM, et al. Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med 2010;49:1603–16.
   PubMed Web of Science ®Google Scholar
• Suissa S, Ernst P, Benayoun S, et al. Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med 2000;343:332–6.
   PubMed Web of Science ®Google Scholar
• Birben E, Sahiner UM, Sackesen C, et al. Oxidative stress and antioxidant defense. World Aller Organ J 2012;5:1.
   PubMedGoogle Scholar
• Santus P, Corsico A, Solidoro P, et al. Oxidative stress and respiratory system: pharmacological and clinical reappraisal of N-acetylcysteine. COPD J Chron Obstruct Pulmon Dis 2014;11:705–17.
   PubMed Web of Science ®Google Scholar
• Sahiner UM, Birben E, Erzurum S, et al. Oxidative stress in asthma. World Allergy Organ J 2011;4:1.
   PubMedGoogle Scholar
• Rahman I, Adcock I. Oxidative stress and redox regulation of lung inflammation in COPD. Eur Respir J 2006;28:219–42.
   PubMed Web of Science ®Google Scholar
• Psathakis K, Mermigkis D, Papatheodorou G, et al. Exhaled markers of oxidative stress in idiopathic pulmonary fibrosis. Eur J Clin Investig 2006;36:362–7.
   PubMed Web of Science ®Google Scholar
• King TE, Pardo A, Selman M. Idiopathic pulmonary fibrosis. Lancet 2011;378:1949–61.
   PubMed Web of Science ®Google Scholar
• Galli F, Battistoni A, Gambari R, et al. Oxidative stress and antioxidant therapy in cystic fibrosis. Biochim Biophys Acta 2012;1822:690–713.
   PubMed Web of Science ®Google Scholar
• Brown R, Wyatt H, Price J, et al. Pulmonary dysfunction in cystic fibrosis is associated with oxidative stress. Eur Respir J 1996;9:334–9.
   PubMed Web of Science ®Google Scholar
• Sosa V, Moliné T, Somoza R, et al. Oxidative stress and cancer: an overview. Ageing Res Rev 2013;12:376–90.
   PubMed Web of Science ®Google Scholar
• Krishna M, Madden J, Teran L, et al. Effects of 0. 2 ppm ozone on biomarkers of inflammation in bronchoalveolar lavage fluid and bronchial mucosa of healthy subjects. Eur Respir J 1998;11:1294–300.
   PubMed Web of Science ®Google Scholar
• Teramoto S, Yu Shu C, Ouchi Y, et al. Increased spontaneous production and generation of superoxide anion by blood neutrophils in patients with asthma. J Asthma 1996;33:149–55.
   PubMed Web of Science ®Google Scholar
• Zuo L, Otenbaker NP, Rose BA, et al. Molecular mechanisms of reactive oxygen species-related pulmonary inflammation and asthma. Mol Immunol 2013;56:57–63.
   PubMed Web of Science ®Google Scholar
• Buhl R, Farmer SG. Current and future pharmacologic therapy of exacerbations in chronic obstructive pulmonary disease and asthma. Proc Am Thorac Soc 2004;1:136–42.
   PubMedGoogle Scholar
• Pauwels RA, Buist AS, Calverley PM, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012;163:1256–76.
   Google Scholar
• Turato G, Zuin R, Miniati M, et al. Airway inflammation in severe chronic obstructive pulmonary disease: relationship with lung function and radiologic emphysema. Am J Respir Crit Care Med 2002;166:105–10.
   PubMed Web of Science ®Google Scholar
• Dragonieri S, Tongoussouva O, Zanini A, et al. Markers of airway inflammation in pulmonary diseases assessed by induced sputum. Monaldi Arch Chest Dis 2016;71:119–26.
   Google Scholar
• Bargagli E, Olivieri C, Bennett D, et al. Oxidative stress in the pathogenesis of diffuse lung diseases: a review. Respir Med 2009;103:1245–56.
   PubMed Web of Science ®Google Scholar
• Donnelly LE, Newton R, Kennedy GE, et al. Anti-inflammatory effects of resveratrol in lung epithelial cells: molecular mechanisms. Am J Physiol Lung Cell Mol Physiol 2004;287:L774–83.
   PubMed Web of Science ®Google Scholar
• Lee M, Kim S, Kwon O-K, et al. Anti-inflammatory and anti-asthmatic effects of resveratrol, a polyphenolic stilbene, in a mouse model of allergic asthma. Int Immunopharmacol 2009;9:418–24.
   PubMed Web of Science ®Google Scholar
• Trotta V, Lee W-H, Loo C-Y, et al. In vitro biological activity of resveratrol using a novel inhalable resveratrol spray-dried formulation. Int J Pharm 2015;491:190–7.
   PubMed Web of Science ®Google Scholar
• Biswas SK, McClure D, Jimenez LA, et al. Curcumin induces glutathione biosynthesis and inhibits NF-κB activation and interleukin-8 release in alveolar epithelial cells: mechanism of free radical scavenging activity. Antioxid Redox Signal 2005;7:32–41.
   PubMed Web of Science ®Google Scholar
• Nanua S, Zick SM, Andrade JE, et al. Quercetin blocks airway epithelial cell chemokine expression. Am J Respir Cell Mol Biol 2006;35:602–10.
   PubMed Web of Science ®Google Scholar
• Ying B, Yang T, Song X, et al. Quercetin inhibits IL-1 beta-induced ICAM-1 expression in pulmonary epithelial cell line A549 through the MAPK pathways. Mol Biol Rep 2009;36:1825–32.
   PubMed Web of Science ®Google Scholar
• Wheeler DS, Catravas JD, Odoms K, et al. Epigallocatechin-3-gallate, a green tea-derived polyphenol, inhibits IL-1β-dependent proinflammatory signal transduction in cultured respiratory epithelial cells. J Nutr 2004;134:1039–44.
   PubMed Web of Science ®Google Scholar
• Lee I-T, Lin C-C, Lee C-Y, et al. Protective effects of (-)-epigallocatechin-3-gallate against TNF-α-induced lung inflammation via ROS-dependent ICAM-1 inhibition. J Nutr Biochem 2013;24:124–36.
   PubMed Web of Science ®Google Scholar
• Yang G-Y, Liao J, Kim K, et al. Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols. Carcinogenesis 1998;19:611–6.
   PubMed Web of Science ®Google Scholar
• Fu H, He J, Mei F, et al. Lung cancer inhibitory effect of epigallocatechin-3-gallate is dependent on its presence in a complex mixture (polyphenon E). Cancer Prev Res (Phila) 2009;2:531–7.
   PubMed Web of Science ®Google Scholar
• Wang J, Li JZ, Lu AX, et al. Anticancer effect of salidroside on A549 lung cancer cells through inhibition of oxidative stress and phospho-p38 expression. Oncol Lett 2014;7:1159–64.
   PubMed Web of Science ®Google Scholar
• Zhang W, Wang X, Chen T. Resveratrol induces mitochondria-mediated AIF and to a lesser extent caspase-9-dependent apoptosis in human lung adenocarcinoma ASTC-a-1 cells. Mol Cell Biochem 2011;354:29–37.
   PubMed Web of Science ®Google Scholar
• Kuo P-L, Chiang L-C, Lin C-C. Resveratrol-induced apoptosis is mediated by p53-dependent pathway in Hep G2 cells. Life Sci 2002;72:23–34.
   PubMed Web of Science ®Google Scholar
• Wu S-H, Hang L-W, Yang J-S, et al. Curcumin induces apoptosis in human non-small cell lung cancer NCI-H460 cells through ER stress and caspase cascade-and mitochondria-dependent pathways. Anticancer Res 2010;30:2125–33.
   PubMed Web of Science ®Google Scholar
• Han G, Xia J, Gao J, et al. Anti-tumor effects and cellular mechanisms of resveratrol. Drug Discov Ther 2015;9:1–12.
   PubMed Web of Science ®Google Scholar
• Yang C-L, Liu Y-Y, Ma Y-G, et al. Curcumin blocks small cell lung cancer cells migration, invasion, angiogenesis, cell cycle and neoplasia through Janus kinase-STAT3 signalling pathway. PLoS One 2012;7:e37960.
   PubMed Web of Science ®Google Scholar
• Venkatesan N, Punithavathi D, Babu M., Protection from acute and chronic lung diseases by curcumin. In: Aggarwal BB, Surth Y-J, Shishoida S, eds. The molecular targets and therapeutic uses of curcumin in health and disease. Berlin, Germany: Springer; 2007:379–405.
   Google Scholar
• Pillai GR, Srivastava AS, Hassanein TI, et al. Induction of apoptosis in human lung cancer cells by curcumin. Cancer Lett 2004;208:163–70.
   PubMed Web of Science ®Google Scholar
• Sadava D, Whitlock E, Kane SE. The green tea polyphenol, epigallocatechin-3-gallate inhibits telomerase and induces apoptosis in drug-resistant lung cancer cells. Biochem Biophys Res Commun 2007;360:233–7.
   PubMed Web of Science ®Google Scholar
• Li G-X, Chen Y-K, Hou Z, et al. Pro-oxidative activities and dose–response relationship of (−)-epigallocatechin-3-gallate in the inhibition of lung cancer cell growth: a comparative study in vivo and in vitro. Carcinogenesis 2010;31:902–10.
   PubMed Web of Science ®Google Scholar
• Tena AF, Clarà PC. Deposition of inhaled particles in the lungs. Arch Bronconeumol 2012;48:240–6.
   PubMed Web of Science ®Google Scholar
• Loira-Pastoriza C, Todoroff J, Vanbever R. Delivery strategies for sustained drug release in the lungs. Adv Drug Deliv Rev 2014;75:81–91.
   PubMed Web of Science ®Google Scholar
• Carvalho TC, Peters JI, Williams RO. Influence of particle size on regional lung deposition-what evidence is there? Int J Pharm 2011;406:1–10.
   PubMed Web of Science ®Google Scholar
• Adi S, Adi H, Tang P, et al. Micro-particle corrugation, adhesion and inhalation aerosol efficiency. Eur J Pharm Sci 2008;35:12–8.
   PubMed Web of Science ®Google Scholar
• Chow AH, Tong HH, Chattopadhyay P, et al. Particle engineering for pulmonary drug delivery. Pharm Res 2007;24:411–37.
   PubMed Web of Science ®Google Scholar
• Bosquillon C, Lombry C, Preat V, et al. Comparison of particle sizing techniques in the case of inhalation dry powders. J Pharm Sci 2001;90:2032–41.
   PubMed Web of Science ®Google Scholar
• Sebti T, Amighi K. Preparation and in vitro evaluation of lipidic carriers and fillers for inhalation. Eur J Pharm Biopharm 2006;63:51–8.
   PubMed Web of Science ®Google Scholar
• Scalia S, Trotta V, Traini D, et al. Incorporation of quercetin in respirable lipid microparticles: effect on stability and cellular uptake on A549 pulmonary alveolar epithelial cells. Colloids Surf B Biointerfaces 2013;112:322–9.
   PubMed Web of Science ®Google Scholar
• Marple VA, Olson BA, Santhanakrishnan K, et al. Next generation pharmaceutical impactor (a new impactor for pharmaceutical inhaler testing). Part II: archival calibration. J Aerosol Med 2003;16:301–24.
   PubMedGoogle Scholar
• Pharmacopoeia B. British pharmacopoeia Appendix XIIC.7. Preparations for inhalation: aerodynamic assessment of fine particles. 2012:345.
   Google Scholar
• US Pharmacopoeia. 601. Aerosols, metered dose inhalers, and dry powder inhalers. US Pharmacopeia 2000;25:1964–80.
   Google Scholar
• Vehring R. Pharmaceutical particle engineering via spray drying. Pharm Res 2008;25:999–1022.
   PubMed Web of Science ®Google Scholar
• Trotta V, Lee W-H, Loo C-Y, et al. Co-spray dried resveratrol and budesonide inhalation formulation for reducing inflammation and oxidative stress in rat alveolar macrophages. Eur J Pharm Sci 2016;86:20–8.
   PubMed Web of Science ®Google Scholar
• Prota L, Santoro A, Bifulco M, et al. Leucine enhances aerosol performance of Naringin dry powder and its activity on cystic fibrosis airway epithelial cells. Int J Pharm 2011;412:8–19.
   PubMed Web of Science ®Google Scholar
• Scalia S, Young PM, Traini D. Solid lipid microparticles as an approach to drug delivery. Expert Opin Drug Deliv 2015;12:583–99.
   PubMed Web of Science ®Google Scholar
• Kurniawansyah F, Mammucari R, Foster NR. Inhalable curcumin formulations by supercritical technology. Powder Technol 2015;284:289–98.
   Web of Science ®Google Scholar
• Zhang J, Lv H, Jiang K, et al. Enhanced bioavailability after oral and pulmonary administration of baicalein nanocrystal. Int J Pharm 2011;420:180–8.
   PubMed Web of Science ®Google Scholar
• Scalia S, Haghi M, Losi V, et al. Quercetin solid lipid microparticles: a flavonoid for inhalation lung delivery. Eur J Pharm Sci 2013;49:278–85.
   PubMed Web of Science ®Google Scholar
• Sanna V, Kirschvink N, Gustin P, et al. Preparation and in vivo toxicity study of solid lipid microparticles as carrier for pulmonary administration. AAPS PharmSciTech 2004;5:17–23.
   Web of Science ®Google Scholar
• Silva LFC, Kasten G, de Campos CEM, et al. Preparation and characterization of quercetin-loaded solid lipid microparticles for pulmonary delivery. Powder Technol 2013;239:183–92.
   Web of Science ®Google Scholar
• Dimer FA, Ortiz M, Pohlmann AR, et al. Inhalable resveratrol microparticles produced by vibrational atomization spray drying for treating pulmonary arterial hypertension. J Drug Deliv Sci Technol 2015;29:152–8.
   Web of Science ®Google Scholar
• Ji P, Yu T, Liu Y, et al. Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics. Drug Des Dev Ther 2016;10:911.
   PubMed Web of Science ®Google Scholar
• Liu X-B, Ye J-X, Quan L-H, et al. Pulmonary delivery of scutellarin solution and mucoadhesive particles in rats. Eur J Pharm Biopharm 2008;70:845–52.
   PubMed Web of Science ®Google Scholar
• Lee W-H, Loo C-Y, Ong H-X, et al. Synthesis and characterization of inhalable flavonoid nanoparticle for lung cancer cell targeting. J Biomed Nanotechnol 2015; 11:1–16.
   PubMed Web of Science ®Google Scholar